ESR1 and metabolic dysfunction-associated steatotic liver disease: It is now recognized that ERα is a key regulator of energy homeostasis and glucose metabolism and that the ERα pathway might represent a potential therapeutic target for the prevention or treatment of insulin resistance, type 2 diabetes mellitus, and non-alcoholic fatty liver diseases [16,32].